Ontology highlight
ABSTRACT:
SUBMITTER: Vennin C
PROVIDER: S-EPMC5777504 | biostudies-literature | 2017 Apr
REPOSITORIES: biostudies-literature
Vennin Claire C Chin Venessa T VT Warren Sean C SC Lucas Morghan C MC Herrmann David D Magenau Astrid A Melenec Pauline P Walters Stacey N SN Del Monte-Nieto Gonzalo G Conway James R W JR Nobis Max M Allam Amr H AH McCloy Rachael A RA Currey Nicola N Pinese Mark M Boulghourjian Alice A Zaratzian Anaiis A Adam Arne A S AA Heu Celine C Nagrial Adnan M AM Chou Angela A Steinmann Angela A Drury Alison A Froio Danielle D Giry-Laterriere Marc M Harris Nathanial L E NL Phan Tri T Jain Rohit R Weninger Wolfgang W McGhee Ewan J EJ Whan Renee R Johns Amber L AL Samra Jaswinder S JS Chantrill Lorraine L Gill Anthony J AJ Kohonen-Corish Maija M Harvey Richard P RP Harvey Richard P RP Biankin Andrew V AV Evans T R Jeffry TR Anderson Kurt I KI Grey Shane T ST Ormandy Christopher J CJ Gallego-Ortega David D Wang Yingxiao Y Samuel Michael S MS Sansom Owen J OJ Burgess Andrew A Cox Thomas R TR Morton Jennifer P JP Pajic Marina M Timpson Paul P
Science translational medicine 20170401 384
The emerging standard of care for patients with inoperable pancreatic cancer is a combination of cytotoxic drugs gemcitabine and Abraxane, but patient response remains moderate. Pancreatic cancer development and metastasis occur in complex settings, with reciprocal feedback from microenvironmental cues influencing both disease progression and drug response. Little is known about how sequential dual targeting of tumor tissue tension and vasculature before chemotherapy can affect tumor response. W ...[more]